{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:28:43Z","timestamp":1792614523236,"version":"4.5.0"},"reference-count":105,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PNT"],"published-print":{"date-parts":[[2021,3,12]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Helminths infections are among the most important problems in animal health and husbandry.\nMoreover, zoonotic helminths endanger rural communities, particularly in developing countries.\nHelminthiasis are not only important in relation to the harmful effects of parasites; additional\nissues like anthelmintic resistance spread became more important over time.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>As new anthelmintic development takes many years and millions of dollars of investment, some\nstrategies are currently focused on the modification of already available drugs, in order to improve\ntheir efficacy and overcome their limitations. In this field, nanotechnology has brought a novel approach,\nshowing advantages like the regulation of the drug\u2019s delivery and kinetics, reaching of specific\ntargets, and possibilities to avoid the systemic spread and side effects.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Taking this into account, the present review aims to introduce some of the current knowledge in anthelmintic\nimprovement based on nanotechnology, and how researchers could benefit from this technology\nin order to overcome the drugs limitations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>Finally, some insights into potential field applications are discussed, based on the most important\nconcerns of current anthelmintic therapy.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/2211738508666200524233724","type":"journal-article","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T06:14:43Z","timestamp":1590387283000},"page":"5-14","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nanotechnological Improvement of Veterinary Anthelmintics"],"prefix":"10.2174","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2716-9653","authenticated-orcid":true,"given":"Rodrigo","family":"Sanabria","sequence":"first","affiliation":[{"name":"Instituto Tecnologico Chascomus (INTECH)-CONICET-UNSAM. Av. Marino KM 8.2, (7130), Chascom\u00fas, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijpara.2016.09.007","volume":"47","author":"Beesley N.J.","year":"2017","unstructured":"Beesley N.J.; Williams D.J.; Paterson S.; Hodgkinson J.; Fasciola hepatica demonstrates high levels of genetic diversity, a lack of population structure and high gene flow: possible implications for drug resistance. Int J Parasitol 2017,47(1),11-20","journal-title":"Int J Parasitol"},{"key":"ref=2","first-page":"16","author":"Boray J.C.","year":"1993","unstructured":"Boray J.C.;  Liver fluke disease in sheep and cattle 1993,16","journal-title":"Liver fluke disease in sheep and cattle"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1365-3156.2002.00870.x","volume":"7","author":"Esteban J.G.","year":"2002","unstructured":"Esteban J.G.; Gonz\u00e1lez C.; Bargues M.D.; High fascioliasis infection in children linked to a man-made irrigation zone in Peru. Trop Med Int Health 2002,7(4),339-348","journal-title":"Trop Med Int Health"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1098\/rstb.2010.0134","volume":"365","author":"Thornton P.K.","year":"2010","unstructured":"Thornton P.K.; Livestock production: Recent trends, future prospects. Philos Trans R Soc Lond B Biol Sci 2010,365(1554),2853-2867","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/ani2010093","volume":"2","author":"Fox N.J.","year":"2012","unstructured":"Fox N.J.; Marion G.; Davidson R.S.; White P.C.; Hutchings M.R.; Livestock helminths in a changing climate: Approaches and restrictions to meaningful predictions. Animals (Basel) 2012,2(1),93-107","journal-title":"Animals (Basel)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpddr.2015.08.001","volume":"5","author":"Geurden T.","year":"2015","unstructured":"Geurden T.; Chartier C.; Fanke J.; Anthelmintic resistance to ivermectin and moxidectin in gastrointestinal nematodes of cattle in Europe. Int J Parasitol Drugs Drug Resist 2015,5(3),163-171","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.pt.2018.05.005","volume":"34","author":"Lanusse C.","year":"2018","unstructured":"Lanusse C.; Canton C.; Virkel G.; Alvarez L.; Costa-Junior L.; Lifschitz A.; Strategies to optimize the efficacy of anthelmintic drugs in ruminants. Trends Parasitol 2018,34(8),664-682","journal-title":"Trends Parasitol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/nrmicro1048","volume":"2","author":"\u00d5mura S.","year":"2004","unstructured":"\u00d5mura S.; Crump A.; The life and times of ivermectin - a success story. Nat Rev Microbiol 2004,2(12),984-989","journal-title":"Nat Rev Microbiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.vetpar.2003.11.003","volume":"119","author":"Lifschitz A.","year":"2004","unstructured":"Lifschitz A.; Sallovitz J.; Imperiale F.; Pis A.; Jauregui Lorda J.; Lanusse C.; Pharmacokinetic evaluation of four ivermectin generic formulations in calves. Vet Parasitol 2004,119(2-3),247-257","journal-title":"Vet Parasitol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0304-4017(94)90094-9","volume":"54","author":"Prichard R.","year":"1994","unstructured":"Prichard R.; Anthelmintic resistance. Vet Parasitol 1994,54(1-3),259-268","journal-title":"Vet Parasitol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.pt.2005.08.014","volume":"21","author":"Geary T.G.","year":"2005","unstructured":"Geary T.G.; Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol 2005,21(11),530-532","journal-title":"Trends Parasitol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0304-4017(97)00065-4","volume":"73","author":"Waruiru R.M.","year":"1997","unstructured":"Waruiru R.M.; Efficacy of closantel, albendazole and levamisole on an ivermectin resistant strain of Haemonchus contortus in sheep. Vet Parasitol 1997,73(1-2),65-71","journal-title":"Vet Parasitol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.vetpar.2019.06.015","volume":"272","author":"Robson D E.","year":"2019","unstructured":"Robson D E.; Matias DA.; Bastos AG.; Anthelmintic efficacy of trichlorfon and blood parameters of young lambs infected with Haemonchus contortus. Vet Parasitol 2019,272,40-43","journal-title":"Vet Parasitol"},{"key":"ref=14","first-page":"147","volume":"8","author":"Jeyahilakan N.","year":"2002","unstructured":"Jeyahilakan N.; Karunakaran P.; Mathivanan R.; Karunanithi K.; Observation on toxic effect of levamisole in small ruminants. Indian J Small Ruminants 2002,8,147-148","journal-title":"Indian J Small Ruminants"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.parint.2010.09.006","volume":"59","author":"Almeida F.A.","year":"2010","unstructured":"Almeida F.A.; Garcia K.C.; Torgerson P.R.; Amarante A.F.; Multiple resistance to anthelmintics by Haemonchus contortus and Trichostrongylus colubriformis in sheep in Brazil. Parasitol Int 2010,59(4),622-625","journal-title":"Parasitol Int"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.livsci.2018.09.022","volume":"217","author":"Buss Baiak B.","year":"2018","unstructured":"Buss Baiak B.; Lehnen C.; Abdallah da Rocha R.; Anthelmintic resistance in cattle: A systematic review and meta-analysis. Livest Sci 2018,217,127-135","journal-title":"Livest Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s13071-019-3828-6","volume":"12","author":"Jimenez Castro P.D.","year":"2019","unstructured":"Jimenez Castro P.D.; Howell S.B.; Schaefer J.J.; Avramenko R.W.; Gilleard J.S.; Kaplan R.M.; Multiple drug resistance in the canine hookworm Ancylostoma caninum: an emerging threat? Parasit Vectors 2019,12(1),576","journal-title":"Parasit Vectors"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224108","volume":"14","author":"Furtado L.F.V.","year":"2019","unstructured":"Furtado L.F.V.; Medeiros C.D.S.; Zuccherato L.W.; First identification of the benzimidazole resistance-associated F200Y SNP in the beta-tubulin gene in Ascaris lumbricoides. PLoS One 2019,14(10)","journal-title":"PLoS One"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"DiMasi J.A.","year":"2016","unstructured":"DiMasi J.A.; Grabowski H.G.; Hansen R.W.; Innovation in the pharmaceutical industry: New estimates of R","journal-title":"J Health Econ"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijpddr.2015.05.001","volume":"5","author":"Bartley D.J.","year":"2015","unstructured":"Bartley D.J.; Devin L.; Nath M.; Morrison A.A.; Selection and characterisation of monepantel resistance in Teladorsagia circumcincta isolates. Int J Parasitol Drugs Drug Resist 2015,5(2),69-76","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.vetpar.2012.09.020","volume":"191","author":"Leathwick D.M.","year":"2013","unstructured":"Leathwick D.M.; Miller C.M.; Efficacy of oral, injectable and pour-on formulations of moxidectin against gastrointestinal nematodes in cattle in New Zealand. Vet Parasitol 2013,191(3-4),293-300","journal-title":"Vet Parasitol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.vetpar.2013.07.037","volume":"198","author":"Scott I.","year":"2013","unstructured":"Scott I.; Pomroy W.E.; Kenyon P.R.; Smith G.; Adlington B.; Moss A.; Lack of efficacy of monepantel against Teladorsagia circumcincta and Trichostrongylus colubriformis. Vet Parasitol 2013,198(1-2),166-171","journal-title":"Vet Parasitol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.3390\/ijms19113299","volume":"19","author":"Bai D.P.","year":"2018","unstructured":"Bai D.P.; Lin X.Y.; Huang Y.F.; Zhang X.F.; Theranostics Aspects of Various Nanoparticles in Veterinary Medicine. Int J Mol Sci 2018,19(11),3299","journal-title":"Int J Mol Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/23144599.2019.1691379","volume":"7","author":"Youssef F.S.","year":"2019","unstructured":"Youssef F.S.; El-Banna H.A.; Elzorba H.Y.; Galal A.M.; Application of some nanoparticles in the field of veterinary medicine. Int J Vet Sci Med 2019,7(1),78-93","journal-title":"Int J Vet Sci Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1021\/nn900002m","volume":"3","author":"Farokhzad O.C.","year":"2009","unstructured":"Farokhzad O.C.; Langer R.; Impact of nanotechnology on drug delivery. ACS Nano 2009,3(1),16-20","journal-title":"ACS Nano"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1021\/cr300014x","volume":"112","author":"Zhou H.C.","year":"2012","unstructured":"Zhou H.C.; Long J.R.; Yaghi O.M.; Introduction to metal-organic frameworks. Chem Rev 2012,112(2),673-674","journal-title":"Chem Rev"},{"key":"ref=27","first-page":"531","author":"Yadav H.","year":"2018","unstructured":"Yadav H.; Almokdad A.; Shaluf S.; Debe M.;  Polymer-based nanomaterials for drug-delivery carriers In: Shyam S Mohapatra, SR, Thomas S, edsNanocarriers for Drug Delivery 2018,531-556","journal-title":"Polymer-based nanomaterials for drug-delivery carriers In: Shyam S Mohapatra, SR, Thomas S, edsNanocarriers for Drug Delivery"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-3121-7_1","author":"Desale S","year":"2016","unstructured":"Desale S; Zhang J; Bronich T.;  Syntetic polymer-based nanomaterials.  Nanomaterials in pharmacology, New York: Springer 2016,1-26","journal-title":"Nanomaterials in pharmacology, New York: Springer"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00436-013-3696-5","volume":"113","author":"Ali M.","year":"2014","unstructured":"Ali M.; Afzal M.; Verma M.; Therapeutic efficacy of poly (lactic-co-glycolic acid) nanoparticles encapsulated ivermectin (nano-ivermectin) against brugian filariasis in experimental rodent model. Parasitol Res 2014,113(2),681-691","journal-title":"Parasitol Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3109\/10837450.2012.693509","volume":"18","author":"Castro S.G.","year":"2013","unstructured":"Castro S.G.; Sanchez Bruni S.F.; Urbizu L.P.; Enhanced dissolution and systemic availability of albendazole formulated as solid dispersions. Pharm Dev Technol 2013,18(2),434-442","journal-title":"Pharm Dev Technol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.vetpar.2014.01.027","volume":"203","author":"Pensel P.E.","year":"2014","unstructured":"Pensel P.E.; Castro S.; Allemandi D.; Bruni S.S.; Palma S.D.; Elissondo M.C.; Enhanced chemoprophylactic and clinical efficacy of albendazole formulated as solid dispersions in experimental cystic echinococcosis. Vet Parasitol 2014,203(1-2),80-86","journal-title":"Vet Parasitol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.actatropica.2018.08.010","volume":"187","author":"Farhadi M.","year":"2018","unstructured":"Farhadi M.; Haniloo A.; Rostamizadeh K.; Faghihzadeh S.; Efficiency of flubendazole-loaded mPEG-PCL nanoparticles: A promising formulation against the protoscoleces and cysts of Echinococcus granulosus. Acta Trop 2018,187,190-200","journal-title":"Acta Trop"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ijpharm.2019.03.011","volume":"561","author":"George A.","year":"2019","unstructured":"George A.; Shah P.A.; Shrivastav P.S.; Natural biodegradable polymers based nano-formulations for drug delivery: A review. Int J Pharm 2019,561,244-264","journal-title":"Int J Pharm"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1039\/c3nr00338h","volume":"5","author":"Hu L.","year":"2013","unstructured":"Hu L.; Sun Y.; Wu Y.; Advances in chitosan-based drug delivery vehicles. Nanoscale 2013,5(8),3103-3111","journal-title":"Nanoscale"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/02652048.2014.944947","volume":"32","author":"Li P.","year":"2015","unstructured":"Li P.; Yang Z.; Wang Y.; Microencapsulation of coupled folate and chitosan nanoparticles for targeted delivery of combination drugs to colon. J Microencapsul 2015,32(1),40-45","journal-title":"J Microencapsul"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3109\/10717544.2013.875603","volume":"22","author":"Wang Y.","year":"2015","unstructured":"Wang Y.; Li P.; Chen L.; Gao W.; Zeng F.; Kong L.X.; Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acidconjugated nanoparticles. Drug Deliv 2015,22(2),191-198","journal-title":"Drug Deliv"},{"key":"ref=37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2020.112495]","volume":"302112495","author":"Rahbar M.","year":"2020","unstructured":"Rahbar M.; Morsali A.; Bozorgmehr M.; Beyrambadi A.; Quantum chemical studies of chitosan nanoparticles as effective drug delivery systems for 5-fluorouracil anticancer drug. J Mol Liq 2020,302112495","journal-title":"J Mol Liq"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.exppara.2013.05.014","volume":"135","author":"Ribeiro W.L.","year":"2013","unstructured":"Ribeiro W.L.; Macedo I.T.; dos Santos J.M.; Activity of chitosan-encapsulated Eucalyptus staigeriana essential oil on Haemonchus contortus. Exp Parasitol 2013,135(1),24-29","journal-title":"Exp Parasitol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s00436-013-3492-2","volume":"112","author":"de Aquino Mesquita M","year":"2013","unstructured":"de Aquino Mesquita M; E Silva J\u00fanior JB; Panassol AM; Anthelmintic activity of Eucalyptus staigeriana encapsulated oil on sheep gastrointestinal nematodes. Parasitol Res 2013,112(9),3161-3165","journal-title":"Parasitol Res"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1208\/s12249-016-0659-z","volume":"18","author":"Priotti J.","year":"2017","unstructured":"Priotti J.; Codina A.V.; Leonardi D.; Vasconi M.D.; Hinrichsen L.I.; Lamas M.C.; Albendazole microcrystal formulations based on chitosan and cellulose derivatives: physicochemical characterization and in vitro parasiticidal activity in Trichinella spiralis adult worms. AAPS PharmSciTech 2017,18(4),947-956","journal-title":"AAPS PharmSciTech"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005945","volume":"12","author":"Ceballos L.","year":"2018","unstructured":"Ceballos L.; Krolewiecki A.; Ju\u00e1rez M.; Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers. PLoS Negl Trop Dis 2018,12(1)","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/00480169.1985.35224","volume":"33","author":"Boray J.C.","year":"1985","unstructured":"Boray J.C.; Jackson R.; Strong M.B.; Chemoprophylaxis of fascioliasis with triclabendazole. N Z Vet J 1985,33(11),182-185","journal-title":"N Z Vet J"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0304-4017(00)00267-3","volume":"91","author":"Moll L.","year":"2000","unstructured":"Moll L.; Gaasenbeek C.P.; Vellema P.; Borgsteede F.H.; Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The Netherlands. Vet Parasitol 2000,91(1-2),153-158","journal-title":"Vet Parasitol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.pt.2016.03.002","volume":"32","author":"Kelley J.M.","year":"2016","unstructured":"Kelley J.M.; Elliott T.P.; Beddoe T.; Anderson G.; Skuce P.; Spithill T.W.; Current threat of triclabendazole resistance in Fasciola hepatica. Trends Parasitol 2016,32(6),458-469","journal-title":"Trends Parasitol"},{"key":"ref=45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207625","volume":"13","author":"Real D.","year":"2018","unstructured":"Real D.; Hoffmann S.; Leonardi D.; Salomon C.; Goycoolea F.M.; Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations. PLoS One 2018,13(12)","journal-title":"PLoS One"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","volume":"56","author":"Wissing S.A.","year":"2004","unstructured":"Wissing S.A.; Kayser O.; M\u00fcller R.H.; Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004,56(9),1257-1272","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","volume":"242","author":"M\u00fcller R.H.","year":"2002","unstructured":"M\u00fcller R.H.; Radtke M.; Wissing S.A.; Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002,242(1-2),121-128","journal-title":"Int J Pharm"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0031-6865(95)00010-7","volume":"70","author":"Vemuri S.","year":"1995","unstructured":"Vemuri S.; Rhodes C.T.; Preparation and characterization of liposomes as therapeutic delivery systems: A review. Pharm Acta Helv 1995,70(2),95-111","journal-title":"Pharm Acta Helv"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1017\/S003118200006635X","volume":"113","author":"Wen H.","year":"1996","unstructured":"Wen H.; New R.R.; Muhmut M.; Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. Parasitology 1996,113(Pt 2),111-121","journal-title":"Parasitology"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.actatropica.2013.06.011","volume":"128","author":"Frezza T.F.","year":"2013","unstructured":"Frezza T.F.; Gremi\u00e3o M.P.; Zanotti-Magalh\u00e3es E.M.; Magalh\u00e3es L.A.; de Souza A.L.; Allegretti S.M.; Liposomal-praziquantel: Efficacy against Schistosoma mansoni in a preclinical assay. Acta Trop 2013,128(1),70-75","journal-title":"Acta Trop"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/10611860310001620707","volume":"11","author":"Owais M.","year":"2003","unstructured":"Owais M.; Misra-Bhattacharya S.; Haq W.; Gupta C.M.; Immunomodulator tuftsin augments antifilarial activity of diethylcarbamazine against experimental Brugian filariasis. J Drug Target 2003,11(4),247-251","journal-title":"J Drug Target"},{"key":"ref=52","first-page":"2367","volume":"6","author":"Xie S.","year":"2011","unstructured":"Xie S.; Pan B.; Shi B.; Solid lipid nanoparticle suspension enhanced the therapeutic efficacy of praziquantel against tapeworm. Int J Nanomedicine 2011,6,2367-2374","journal-title":"Int J Nanomedicine"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s13071-019-3719-x","volume":"12","author":"Ahmadpour E.","year":"2019","unstructured":"Ahmadpour E.; Godrati-Azar Z.; Spotin A.; Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis. Parasit Vectors 2019,12(1),469","journal-title":"Parasit Vectors"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00436-016-4937-1","volume":"115","author":"Gamboa G.V.","year":"2016","unstructured":"Gamboa G.V.; Palma S.D.; Lifschitz A.; Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications. Parasitol Res 2016,115(5),1945-1953","journal-title":"Parasitol Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","volume":"57","author":"Duncan R.","year":"2005","unstructured":"Duncan R.; Izzo L.; Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 2005,57(15),2215-2237","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1142\/S1793292011002871","volume":"06","author":"Szymanski P.","year":"2011","unstructured":"Szymanski P.; Markowicz M.; Mikiciuk-Olasik E.; Nanotechnology in pharmaceutical and biomedical applications: Dendrimers. Nano 2011,06,509-539","journal-title":"Nano"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.18388\/abp.2001_5127","volume":"48","author":"Klajnert B.","year":"2001","unstructured":"Klajnert B.; Bryszewska M.; Dendrimers: properties and applications. Acta Biochim Pol 2001,48(1),199-208","journal-title":"Acta Biochim Pol"},{"key":"ref=58","author":"Garg T","year":"2011","unstructured":"Garg T; Singh O; Arora S; Murthy R.;  Dendrimer: a novel scaffold for drug delivery 2011","journal-title":"Dendrimer: a novel scaffold for drug delivery"},{"key":"ref=59","first-page":"142","volume":"3","author":"Tripathy S.","year":"2013","unstructured":"Tripathy S.; Das M.; Dendrimers and their applications as novel drug delivery carriers. J Appl Pharm Sci 2013,3,142-149","journal-title":"J Appl Pharm Sci"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1590\/S0104-66322011000400013","volume":"28","author":"Fern\u00e1ndez L.","year":"2011","unstructured":"Fern\u00e1ndez L.; Sigal E.; Otero L.; Silber J.; Santo M.; Solubility improvement of an anthelmintic benzimidazole carbamate by association with dendrimers. Braz J Chem Eng 2011,28,679-689","journal-title":"Braz J Chem Eng"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejpb.2015.10.015","volume":"102","author":"Mansuri S.","year":"2016","unstructured":"Mansuri S.; Kesharwani P.; Tekade R.K.; Jain N.K.; Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole. Eur J Pharm Biopharm 2016,102,202-213","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijpharm.2005.07.023","volume":"304","author":"Devarakonda B.","year":"2005","unstructured":"Devarakonda B.; Hill R.A.; Liebenberg W.; Brits M.; de Villiers M.M.; Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins. Int J Pharm 2005,304(1-2),193-209","journal-title":"Int J Pharm"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/molecules22081370","volume":"22","author":"Aderibigbe B.A.","year":"2017","unstructured":"Aderibigbe B.A.; Metal-based nanoparticles for the treatment of infectious diseases. Molecules 2017,22(8),1370","journal-title":"Molecules"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jviromet.2015.06.010","volume":"222","author":"Hang X.","year":"2015","unstructured":"Hang X.; Peng H.; Song H.; Qi Z.; Miao X.; Xu W.; Antiviral activity of cuprous oxide nanoparticles against Hepatitis C Virus in vitro. J Virol Methods 2015,222,150-157","journal-title":"J Virol Methods"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12906-016-1219-5","volume":"16","author":"Rashid M.M.","year":"2016","unstructured":"Rashid M.M.; Ferdous J.; Banik S.; Islam M.R.; Uddin A.H.; Robel F.N.; Anthelmintic activity of silver-extract nanoparticles synthesized from the combination of silver nanoparticles and M. charantia fruit extract. BMC Complement Altern Med 2016,16,242","journal-title":"BMC Complement Altern Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"e02505","DOI":"10.1128\/AAC.02505-16","volume":"61","author":"Choi S.R.","year":"2017","unstructured":"Choi S.R.; Britigan B.E.; Narayanasamy P.; Ga (III) nanoparticles inhibit growth of both Mycobacterium tuberculosis and HIV and release of interleukin-6 (IL-6) and IL-8 in coinfected macrophages. Antimicrob Agents Chemother 2017,61(4),e02505-e02516","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=67","first-page":"1603","volume":"3","author":"Tikariha S.","year":"2012","unstructured":"Tikariha S.; Singh S.; Banerjee S.; Vidyarthi A.; Biosynthesis of gold nanoparticles, scope and applications: a review. Int J Pharm Res 2012,3,1603-1615","journal-title":"Int J Pharm Res"},{"key":"ref=68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084693","volume":"9","author":"Kar P.K.","year":"2014","unstructured":"Kar P.K.; Murmu S.; Saha S.; Tandon V.; Acharya K.; Anthelmintic efficacy of gold nanoparticles derived from a phytopathogenic fungus, Nigrospora oryzae. PLoS One 2014,9(1)","journal-title":"PLoS One"},{"key":"ref=69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133086","volume":"10","author":"Khan Y.A.","year":"2015","unstructured":"Khan Y.A.; Singh B.R.; Ullah R.; Shoeb M.; Naqvi A.H.; Abidi S.M.; Anthelmintic effect of biocompatible zinc oxide nanoparticles (ZnO NPs) on Gigantocotyle explanatum, a neglected parasite of indian water buffalo. PLoS One 2015,10(7)","journal-title":"PLoS One"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.exppara.2019.02.005","volume":"198","author":"Rehman A.","year":"2019","unstructured":"Rehman A.; Ullah R.; Uddin I.; Zia I.; Rehman L.; Abidi S.M.A.; In vitro anthelmintic effect of biologically synthesized silver nanoparticles on liver amphistome, Gigantocotyle explanatum. Exp Parasitol 2019,198,95-104","journal-title":"Exp Parasitol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1751-0813.1988.tb14443.x","volume":"65","author":"Rolfe P.F.","year":"1988","unstructured":"Rolfe P.F.; Boray J.C.; Chemotherapy of paramphistomosis in sheep. Aust Vet J 1988,65(5),148-150","journal-title":"Aust Vet J"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.vetpar.2014.09.022","volume":"206","author":"Sanabria R.","year":"2014","unstructured":"Sanabria R.; Moreno L.; Alvarez L.; Lanusse C.; Romero J.; Efficacy of oxyclozanide against adult Paramphistomum leydeni in naturally infected sheep. Vet Parasitol 2014,206(3-4),277-281","journal-title":"Vet Parasitol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40089-016-0198-3","volume":"7","author":"Dorostkar R.","year":"2017","unstructured":"Dorostkar R.; Ghalavand M.; Nazarizadeh A.; Tat M.; Hasemzadeh M.; Anthelmintic effects of zinc oxide and iron oxide nanoparticles against Toxocara vitulorum. Int Nano Lett 2017,7,157","journal-title":"Int Nano Lett"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0001-706X(03)00031-7","volume":"86","author":"Dayan A.D.","year":"2003","unstructured":"Dayan A.D.; Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop 2003,86(2-3),141-159","journal-title":"Acta Trop"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00436-002-0751-z","volume":"90","author":"Cioli D.","year":"2003","unstructured":"Cioli D.; Pica-Mattoccia L.; Praziquantel. Parasitol Res 2003,90(Suppl. 1),S3-S9","journal-title":"Parasitol Res"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.01.014","author":"Meteleva E.","year":"2019","unstructured":"Meteleva E.; Chistyachenko Y.; Suntsova L.;  Disodium salt of glycyrrhizic acid \u2013 A novel supramolecular delivery system for anthelmintic drug praziquantel 2019","journal-title":"Disodium salt of glycyrrhizic acid \u2013 A novel supramolecular delivery system for anthelmintic drug praziquantel"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1080\/03639045.2018.1438461","volume":"44","author":"Vinarov Z.","year":"2018","unstructured":"Vinarov Z.; Gancheva G.; Katev V.; Tcholakova S.S.; Albendazole solution formulation via vesicle-to-micelle transition of phospholipid-surfactant aggregates. Drug Dev Ind Pharm 2018,44(7),1130-1138","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1128\/AAC.04875-14","volume":"59","author":"El-Feky G.S.","year":"2015","unstructured":"El-Feky G.S.; Mohamed W.S.; Nasr H.E.; El-Lakkany N.M.; Seif El-Din S.H.; Botros S.S.; Praziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection. Antimicrob Agents Chemother 2015,59(6),3501-3508","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jddst.2017.11.003","volume":"43","author":"Koradia K.","year":"2018","unstructured":"Koradia K.; Parikh R.; Koraida H.; Albendazole nanocrystals: Optimization, spectroscopic, thermal and anthelmintic studies. J Drug Deliv Sci Technol 2018,43,369-378","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=80","first-page":"90","volume":"2","author":"Mohanty N.","year":"2014","unstructured":"Mohanty N.; Palai T.; Prusty B.; Mohapatra J.; An overview of nanomedicine in veterinary science. Vet Res (Faisalabad) 2014,2,90-95","journal-title":"Vet Res (Faisalabad)"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.crci.2015.07.009","volume":"18","author":"Shakir M.","year":"2015","unstructured":"Shakir M.; Faraz M.; Shoeb Khan M.; Al-Resayes S.; The photocatalytic, in vitro anthelmintic activity of biomolecule-inspired CDS nanoparticles. C R Chim 2015,18,966-978","journal-title":"C R Chim"},{"key":"ref=82","first-page":"1","volume":"20","author":"Bahadar H.","year":"2016","unstructured":"Bahadar H.; Maqbool F.; Niaz K.; Abdollahi M.; Toxicity of nanoparticles and an overview of current experimental models. Iran Biomed J 2016,20(1),1-11","journal-title":"Iran Biomed J"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/toxsci\/kfn256","volume":"107","author":"Griffitt R.J.","year":"2009","unstructured":"Griffitt R.J.; Hyndman K.; Denslow N.D.; Barber D.S.; Comparison of molecular and histological changes in zebrafish gills exposed to metallic nanoparticles. Toxicol Sci 2009,107(2),404-415","journal-title":"Toxicol Sci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.2147\/IJN.S212907","volume":"14","author":"Yao Y.","year":"2019","unstructured":"Yao Y.; Zang Y.; Qu J.; Tang M.; Zhang T.; The toxicity of metallic nanoparticles on liver: the subcellular damages, mechanisms, and outcomes. Int J Nanomedicine 2019,14,8787-8804","journal-title":"Int J Nanomedicine"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1039\/C6TX00444J","volume":"6","author":"Liu F.","year":"2017","unstructured":"Liu F.; Chang X.; Tian M.; Nano NiO induced liver toxicity via activating the NF-\u03baB signaling pathway in rats. Toxicol Res (Camb) 2017,6(2),242-250","journal-title":"Toxicol Res (Camb)"},{"key":"ref=86","first-page":"1393","volume":"9","author":"Magaye R.R.","year":"2014","unstructured":"Magaye R.R.; Yue X.; Zou B.; Acute toxicity of nickel nanoparticles in rats after intravenous injection. Int J Nanomedicine 2014,9,1393-1402","journal-title":"Int J Nanomedicine"},{"key":"ref=87","first-page":"159","volume":"11","author":"Suker D.K.","year":"2018","unstructured":"Suker D.K.; Jasim F.A.; Liver histopathological alteration after repeated intra-tracheal instillation of titanium dioxide in male rats. Gastroenterol Hepatol Bed Bench 2018,11(2),159-168","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1021\/nn302502u","volume":"6","author":"Bartneck M.","year":"2012","unstructured":"Bartneck M.; Ritz T.; Keul H.A.; Peptide-functionalized gold nanorods increase liver injury in hepatitis. ACS Nano 2012,6(10),8767-8777","journal-title":"ACS Nano"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.envpol.2008.10.002","volume":"157","author":"Auffan M.","year":"2009","unstructured":"Auffan M.; Rose J.; Wiesner M.R.; Bottero J.Y.; Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro. Environ Pollut 2009,157(4),1127-1133","journal-title":"Environ Pollut"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1021\/nl0347334","volume":"4","author":"Derfus A.M.","year":"2004","unstructured":"Derfus A.M.; Chan W.C.W.; Bhatia S.N.; Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004,4(1),11-18","journal-title":"Nano Lett"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nnano.2008.111","volume":"3","author":"Poland C.A.","year":"2008","unstructured":"Poland C.A.; Duffin R.; Kinloch I.; Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008,3(7),423-428","journal-title":"Nat Nanotechnol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.toxlet.2009.04.017","volume":"189","author":"Cho M.","year":"2009","unstructured":"Cho M.; Cho W.S.; Choi M.; The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett 2009,189(3),177-183","journal-title":"Toxicol Lett"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.toxlet.2007.09.008","volume":"175","author":"Cho W.S.","year":"2007","unstructured":"Cho W.S.; Choi M.; Han B.S.; Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol Lett 2007,175(1-3),24-33","journal-title":"Toxicol Lett"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijpddr.2012.04.001","volume":"2","author":"Prichard R.","year":"2012","unstructured":"Prichard R.; M\u00e9nez C.; Lespine A.; Moxidectin and the avermectins: Consanguinity but not identity. Int J Parasitol Drugs Drug Resist 2012,2,134-153","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.exppara.2012.04.014","volume":"131","author":"Lloberas M.","year":"2012","unstructured":"Lloberas M.; Alvarez L.; Entrocasso C.; Virkel G.; Lanusse C.; Lifschitz A.; Measurement of ivermectin concentrations in target worms and host gastrointestinal tissues: influence of the route of administration on the activity against resistant Haemonchus contortus in lambs. Exp Parasitol 2012,131(3),304-309","journal-title":"Exp Parasitol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.vetpar.2018.12.016","volume":"266","author":"Fazzio L.","year":"2019","unstructured":"Fazzio L.; Moreno L.; Galvan W.; Pharmacokinetic profile and anthelmintic efficacy of moxidectin administered by different doses and routes to feedlot calves. Vet Parasitol 2019,266,73-79","journal-title":"Vet Parasitol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.vetpar.2016.07.031","volume":"227","author":"Leathwick D.M.","year":"2016","unstructured":"Leathwick D.M.; Miller C.M.; Sauermann C.W.; The efficacy and plasma profiles of abamectin plus levamisole combination anthelmintics administered as oral and pour-on formulations to cattle. Vet Parasitol 2016,227,85-92","journal-title":"Vet Parasitol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/cmdc.200700121","volume":"2","author":"Zhang L.","year":"2007","unstructured":"Zhang L.; Radovic-Moreno A.F.; Alexis F.; Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. ChemMedChem 2007,2(9),1268-1271","journal-title":"ChemMedChem"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1039\/c3cc49003c","volume":"50","author":"Huang F.","year":"2014","unstructured":"Huang F.; You M.; Chen T.; Zhu G.; Liang H.; Tan W.; Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells. Chem Commun (Camb) 2014,50(23),3103-3105","journal-title":"Chem Commun (Camb)"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/BTT.S38387","volume":"8","author":"Skalko-Basnet N.","year":"2014","unstructured":"Skalko-Basnet N.; Biologics: the role of delivery systems in improved therapy. Biologics 2014,8,107-114","journal-title":"Biologics"},{"key":"ref=101","first-page":"2321","volume":"6","author":"Jiao Z.","unstructured":"Jiao Z.; Chen Y.; Wan Y.; Zhang H.; Jiao Z.; Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles. Int J Nanomed ,6,2321","journal-title":"Int J Nanomed"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.4155\/fmc-2018-0439","volume":"11","author":"Singh B.","year":"2019","unstructured":"Singh B.; Varikuti S.; Halsey G.; Volpedo G.; Hamza O.M.; Satoskar A.R.; Host-directed therapies for parasitic diseases. Future Med Chem 2019,11(15),1999-2018","journal-title":"Future Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1046\/j.1365-3083.1998.00251.x","volume":"47","author":"Macedo M.S.","year":"1998","unstructured":"Macedo M.S.; Faquim-Mauro E.; Ferreira A.P.; Abrahamsohn I.A.; Immunomodulation induced by Ascaris suum extract in mice: effect of anti-interleukin-4 and anti-interleukin-10 antibodies. Scand J Immunol 1998,47(1),10-18","journal-title":"Scand J Immunol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"852","DOI":"10.2174\/1389450115666140807154810","volume":"15","author":"Oyinloye B.","year":"2014","unstructured":"Oyinloye B.; Adenowo F.; Gxaba N.; Kappo A.; The promise of antimicrobial peptides for treatment of human schistosomiasis. Curr Drug Targets 2014,15(9),852-859","journal-title":"Curr Drug Targets"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2217\/nnm.09.37","volume":"4","author":"Nowacek A.","year":"2009","unstructured":"Nowacek A.; Kosloski L.M.; Gendelman H.E.; Neurodegenerative disorders and nanoformulated drug development. Nanomedicine (Lond) 2009,4(5),541-555","journal-title":"Nanomedicine (Lond)"}],"container-title":["Pharmaceutical Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/182245","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/182245\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/182245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T21:12:01Z","timestamp":1632517921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/182245\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2211738508666200524233724","relation":{},"ISSN":["2211-7385"],"issn-type":[{"value":"2211-7385","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}